NCT06426745Completed
Split-dose Versus Single-dose Bowel Preparation for Colonoscopy
Source: ClinicalTrials.gov · Last updated 23 May 2024
Brief summary (registry, in English)
Colonoscopy is the current standard method for evaluation of colonic disorders such as colorectal cancer, IBD, polyps, and other conditions.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 180 (actual)
- First submitted
- 19 May 2024
- Start date
- 1 Nov 2022
- Primary completion date
- 25 Oct 2023
- Lead sponsor
- Egymedicalpedia
- Diseases
- Colorectal cancer
- NCT number
- NCT06426745
What you commit to
- Study type: Interventional
- Participants enrolled: 180
- From 1 Nov 2022 to the primary completion date, 25 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Sever congestive heart failure (NHYA III or IV).
- History of bowel obstruction or resection.
- Known allergies to polyethylene glycol.
- Signs of liver cell failure as ascites and hepatic encephalopathy.
Lab values
- Presence of sever renal impairment. (Creatinine clearance \< 30 ml/min or patient on hemodialysis).
Other
- Pregnant woman.
- Refusal of consent for the study.
- Electrolytes disturbances
Who the study is looking for
- \- All patients undergoing elective colonoscopy
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mansoura university Hospital Coordinator of this site? Confirm its status | Al Mansurah | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.